Scalper1 News
Big money flowed into pharma Tuesday as Novartis, GlaxoSmithKline and Eli Lilly unveiled a giant swap of businesses, while Valeant Pharmaceuticals bid roughly $47 billion for Allergan. Novartis (NVS) agreed to buy Glaxo’s (GSK) oncology business for $14.5 billion, plus up to $1.5 billion in milestone payments depending on how products in the pipeline fare. In turn, Glaxo will pay $7.1 billion for Novartis’ vaccines business. Novartis said it’ll Scalper1 News
Scalper1 News